Complexica Pty Ltd, a leading provider of Artificial Intelligence software for optimising sales and marketing decisions, announced today that it has won a tender at Pfizer Australia for the deployment of its What-if Simulator & Optimiser, powered by Complexica’s award-winning Artificial Intelligence platform, Larry, the Digital Analyst®.
“After evaluating a number of software companies in the marketplace that possess advanced prediction and optimisation capabilities, we have ultimately selected Complexica as our vendor of choice.” said Andrew Endicott, Brand Manager for Pfizer Australia. “We have found that answering complex “what-if” questions is a challenging and time-consuming endeavour, and we believe that Complexica’s What-if Simulator & Optimiser can provide Pfizer Australia with a platform for scenario analysis that will improve our decision-making in the future. We look forward to working with Complexica to address some of the analytical and “what-if” challenges facing our business and operating environment.”
Pfizer Australia is part of Pfizer, Inc., which is the world's largest research-based pharmaceutical company, employing more than 96,000 people globally and turning over in excess of $52 billion annually. The company's key areas of focus are immunology, oncology, cardiology, diabetology/endocrinology, and neurology. Since being founded in 1849, the company has been committed to applying science and its global resources to improve health and well-being at every stage of life. For more information about Pfizer, please visit: www.pfizer.com
Complexica’s What-if Simulator & Optimiser will provide Pfizer Australia with the ability to test and optimise a variety of complex what-if scenarios based on large internal and external datasets. In particular, the software will allow Pfizer Australia to:
- Simulate the impact of various sales & marketing strategies
- Answer complex what-if questions that contain many variables and “moving parts” that impact one another in a probabilistic manner
- Investigate a variety of assumptions and hypothesis that are difficult to test in the real-world
- Compare the outcome of various what-if scenarios and analyse the key drivers behind the differences
- Understand the deterministic and non-deterministic factors present in the operations of the business
“Complexica is delighted to have been selected by one of the world’s largest pharmaceutical companies for the provision of software and services in this very important and challenging area,” said Dr. Zbigniew Michalewicz, Chief Scientist of Complexica. “We look forward to applying our software, science, and know-how to help Pfizer Australia answer complex questions and optimise some of their decisions and strategies going forward.”
